When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The new drug is meant to treat specific types of advanced breast cancer which are resistant to hormone therapy.

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

such as a hormone therapy drug. Your doctor may recommend hormone therapy if you have platinum-resistant endometrial cancer that’s progesterone receptor (PR) positive, estrogen receptor (ER ...

Your doctor may recommend chemo, hormone, or targeted therapy. Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of ...

Despite significant therapeutic advances, breast cancer remains a leading ... typically involves several years of hormone therapy. Although these drugs are better tolerated than chemotherapy ...

Despite significant therapeutic advances, breast cancer remains a leading ... typically involves several years of hormone therapy. Although these drugs are better tolerated than chemotherapy ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

The drug, known as datopotamab deruxtecan ... negative tumors that have already been treated with hormone therapy and chemotherapy. Breast cancer is the most common cancer (after skin cancer ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.